Motion for a European Parliament resolution on creating a European compensation fund for victims of the ‘COVID-19 vaccines’
The European Parliament,
– having regard to Rule 143 of its Rules of Procedure,
A. whereas the European Medicines Agency (EMA) has already recorded around a million cases of people experiencing adverse reactions from the COVID-19 vaccines:
– 435 779 due to the Pfizer BioNTech vaccine,
– 373 285 due to the AstraZeneca vaccine,
– 117 243 due to the Moderna vaccine,
– 27 694 due to the Janssen vaccine;
B. whereas these adverse reactions are sometimes severe; whereas around 75 000 people suffered from serious neurological effects as a result of taking the Pfizer vaccine;
C. whereas the EMA states that around 5 000 people have died in the EU as a result of taking the COVID-19 vaccines:
– 4 198 due to the Pfizer vaccine,
– 1 053 due to the AstraZeneca vaccine,
– 392 due to the Moderna vaccine,
– 138 due to the Janssen vaccine;
D. whereas the European Commission negotiated the purchase contracts and did not wish for the pharmaceutical companies to incur any liability; whereas MEPs were not granted access to the contracts during the negotiations;
1. Calls on the Commission to create a European compensation fund for victims of the COVID-19 vaccines;
2. Instructs its President to forward this resolution to the Commission and the Member States.
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.